Latest 8-K filings

TransCode Therapeutics announced updated Phase 1a clinical trial data for TTX-MC138, showing significant disease stabilization and extended treatment duration in advanced cancer patients.

Adicet Bio announced positive safety and efficacy data from its Phase 1 study of prula-cel in patients with Systemic Lupus Erythematosus (SLE) with or without Lupus Nephritis (LN), showing high remission rates and a favorable safety profile.

Fate Therapeutics announced a $15 million grant from the California Institute for Regenerative Medicine (CIRM) to support its Phase 2 clinical trial of FT819 for lupus nephritis.

Volato Group's Alignment Engine subsidiary has signed two take-or-pay orders totaling $1.17 billion for dedicated AI infrastructure with a large AI customer.

4D Molecular Therapeutics has enrolled the first patients in its Phase 3 trial for 4D-150 in diabetic macular edema and released encouraging 2-year data from its SPECTRA trial.

BGC Group, Inc. has announced an update to its financial outlook for the third quarter of 2026, reaffirming previously issued guidance for revenue and pre-tax Adjusted Earnings.

Mirum Pharmaceuticals announced FDA approval for Atebrioz to treat fibrodysplasia ossificans progressiva and positive Phase 3 results for brelovitug in chronic hepatitis delta.

Lakeshore Acquisition III Corp. has extended its deadline to consummate its initial business combination by one month to November 1, 2026, following a third extension payment.

Keros Therapeutics has dosed the first patient in its Phase 2 clinical trial for rinvatercept, a novel therapeutic aimed at treating Duchenne muscular dystrophy (DMD).

Ainos, Inc. has entered into a global exclusive license agreement with BioPhoenix Co., Ltd. for its VELDONA low-dose oral interferon alpha technology platform, securing an initial $600,000 fee and potential future revenue.

SHF Holdings, Inc. announced its Board of Directors has approved a 1-for-12 reverse stock split of its common stock, expected to become effective September 30, 2026.

Matinas BioPharma Holdings, Inc. has filed a Form 8-K announcing a 1-for-15 reverse stock split of its common stock, effective September 28, 2026, to adjust its share structure.

Strategy Inc. provided an update on its at-the-market offering, bitcoin holdings, and share repurchase programs, detailing significant activity in Class A Common Stock and Bitcoin purchases.

Strive, Inc. announced a significant purchase of 1,107 bitcoin and provided an update on its cash, digital asset, and stock holdings as of September 25, 2026.

TransDigm Group Incorporated has successfully completed the acquisition of Prince & Izant, a specialist in brazing alloys and metal components, for approximately $1.066 billion.

News Corporation provided an update on its ongoing $1 billion stock repurchase program, detailing recent buyback activity for its Class A and Class B common stock.

Valley National Bancorp announced its definitive agreement to acquire Bluevine Inc. for approximately $340 million, aiming to accelerate digital small business growth and enhance core funding.

Soluna Holdings announced an amendment to its agreement with Bitdeer Technologies Group, increasing the total deployment at Project Kati 1 to 35 MW and approximately 2.42 EH/s.

Hut 8 Corp. announced the closing of a $1.07 billion senior secured revolving credit facility, enhancing its corporate liquidity and funding capacity.

Ramaco Resources announced a $30.0 million jury verdict in its favor against Federal Insurance Company and ACE American Insurance Company related to a 2018 silo failure.

Eton Pharmaceuticals announces the U.S. commercial availability of IMPAVIDO (miltefosine) capsules, a treatment for rare diseases, alongside comprehensive patient support programs.

Brixmor Property Group and Everview Partners are acquiring Slate Grocery REIT for $2.34 billion, with Brixmor directly acquiring 23 centers and forming a joint venture for the remaining 92.

Vestis Corporation announced the appointment of Russell Tiejema as its new Executive Vice President and Chief Financial Officer, effective September 28, 2026, and reaffirmed its fiscal year 2026 financial outlook.

Flutter Entertainment has ceased its sports betting and iGaming operations in Brazil following a provisional executive order banning such activities, impacting 2026 revenue and EBITDA.

Moleculin Biotech announced the publication of a peer-reviewed analysis demonstrating Annamycin's lack of cardiotoxicity in patients, even at doses exceeding traditional anthracycline limits.

Jaguar Health, Inc. has exchanged a portion of its outstanding debt for shares of its common stock, reducing its principal balance by $3.4 million.

Coeur Mining, Inc. has released an updated corporate presentation on its website, providing new information to stakeholders.

Perpetua Resources Corp. has published an investor presentation for use in investor relations and other purposes.

FTAI Infrastructure Inc. announced its subsidiary has entered into a definitive agreement to acquire the Port Arthur Terminal and a 50% interest in a Diluent Recovery Unit for approximately $255 million.

U.S. GoldMining Inc. announces the completion of a 2026 surface exploration program at its Whistler Gold-Copper Project in Alaska, expanding its pipeline of high-priority drill targets.